Sep 27, 2017 Cellectar Biosciences Reports Cohort Four Data and Partial Response in Relapsed or Refractory Multiple Myeloma Patient Treated with CLR 131 Learn More
Sep 21, 2017 Cellectar Biosciences Enters into Strategic Collaboration with Onconova Therapeutics to Develop New Phospholipid Drug Conjugates Learn More
Sep 20, 2017 Cellectar Biosciences to Present at the Ladenburg Thalmann 2017 Healthcare Conference Learn More